Ceo
CurrentSTAR Medical SA, founded in 2011 and headquartered in Wavre, Belgium, is a medical technology company focused on the development and commercialization of novel ophthalmic implants. MINIject® is iSTAR Medical’s most advanced product, and is approved in Europe for the treatment of Glaucoma – the leading cause of irreversible blindness. Minimally-Invasive Glaucoma Surgery (MIGS) devices are considered the future in glaucoma treatment. In clinical trials, MINIject has been shown to provide safe, meaningful and sustained treatment to lower eye pressure for patients with primary, open-angle glaucoma.iSTAR Medical is backed by leading VC investors. It also concluded a strategic alliance with AbbVie to accelerate the goal to bring MINIject to more patients globally.